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Abstract
High-income countries are experiencing an obesity epidemic that follows a socioeco-
nomic gradient, affecting groups of lower socioeconomic status disproportionately.
Recent clinical findings have suggested new perspectives for the prevention and
treatment of obesity, using personalized dietary approaches. Precision nutrition (PN),
also called personalized nutrition, has been developed to deliver more preventive and
practical dietary advice than ‘one-size-fits-all’ guidelines. With interventions becoming
increasingly plausible at a large scale thanks to artificial intelligence and smartphone
applications, some have begun to view PN as a novel way to deliver the right dietary
intervention to the right population. We argue that large-scale PN, if taken alone, might
be of limited interest from a public health perspective. Building on Geoffrey Rose’s
theory regarding the differences in individual and population causes of disease, we show
that large-scale PN can only address some individual causes of obesity (causes of cases).
This individual-centred approach is likely to have a small impact on the distribution of
obesity at a population level because it ignores the population causes of obesity (causes
of incidence). The latter are embedded in the populations’ social, cultural, economic and
political contexts that make environments obesogenic. Additionally, the most socially
privileged groups in the population are the most likely to respond to large-scale PN
interventions. This could have the undesirable effect of widening social inequalities in
obesity. We caution public health actors that interventions based only on large-scale PN
are unlikely, despite current expectations, to improve dietary intake or reduce obesity at
a population level.
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Introduction
Most high-income countries are experiencing an obesity
epidemic, since 1975.1 For example, in the USA, more than
one in three adults and one in six children were estimated
to be obese in 2015.2 Obesity has been linked to
numerous non-communicable diseases such as diabetes,
cardiovascular disease, osteoarthritis and certain forms of
cancer.3–5 According to the 2016 Global Burden of
Disease,6 an unbalanced diet, obesity, and high fasting
plasma glucose were among the top six leading risk factors
for disability-adjusted life-years in high-income countries.
In these countries, the incidence and prevalence of obesity
follows a socioeconomic gradient, whereby individuals
with lower education, occupation and income are dispro-
portionally affected.7–9 In Spain, Italy and France for in-
stance, the least educated women are over four times as
likely to be obese as the most educated ones.10
Diet is a major modifiable determinant of obesity.
Multiple public health interventions to improve population
dietary intake have been implemented to date. Some
individual-centred interventions have aimed at providing in-
formation about healthy eating. They used, for example,
mass campaigns to disseminate dietary guidelines (e.g. ‘5 a
day’) and food guides (e.g. MyPlate in the USA).11–13 More
recent interventions have focused on shaping the food envi-
ronment through structural measures. Classical examples
are compulsory nutritional standards for school meals14,15
or taxes on sugar-sweetened beverages.16–18 So far out-
comes have been disappointing. People largely fail to follow
the dietary guidelines.19–22 As for obesity, the prevalence
has not declined,2,23 and social inequalities in diet24 and
obesity10,25,26 have persisted or even increased.
Recent research findings,27–35 particularly by Zeevi
et al.36 have suggested new perspectives for the prevention
and treatment of obesity-related diseases, using personalized
dietary approaches. Precision nutrition (PN), also called per-
sonalized nutrition, is based on the postulate that the
optimal diet is not the same for everyone. In brief, PN aims
at delivering tailored nutritional recommendations based on
combined information from individuals’ gut microbiota, ge-
netic, physiological, and behavioural backgrounds.37–42
Following these promising results in clinical re-
search,27–36 some large public research funders, such as the
EU Horizon 2020 programme,43 have encouraged
researchers to test solutions providing tailored nutritional
advice to large numbers of people, including healthy indi-
viduals. An international trial, Food4Me, was recently
launched with 1600 volunteers to test the opportunities
and challenges of PN in the general population.44 Within
this context, some39,42,45,46 have begun to consider PN as
an emerging tool for public health to reduce obesity and
obesity-related diseases, notably because precision
approaches have a marked preventive component.
In parallel, advances in ‘omics’ technologies and wear-
able devices facilitate less costly collection and analysis of
massive data. This makes scaleable delivery of tailored nu-
tritional advice increasingly plausible.38,39,42 Thanks to
these technical developments and the clinical context
explained above, PN could be viewed as a novel opportunity
to provide the right dietary intervention to the right popula-
tion at the right time, and on a large scale.47–49 In this paper,
we explore the promises and potential limitations of inter-
ventions based on large-scale PN. We question their rele-
vance in balancing individuals’ diet and addressing obesity
at a population level. We build our argument on Geoffrey
Rose’s theory50,51 regarding the differences in individual
and population causes of disease. We finally argue that
large-scale PN could possibly have the unintended effect of
exacerbating social inequalities in obesity.
What is large-scale precision nutrition?
Modelled after PN in clinical settings,36 large-scale PN
relies on the collection and analysis of several types of data
Key Messages
• Some public health actors have begun to view large-scale precision nutrition as a novel opportunity to provide the
right dietary intervention to the right population at the right time.
• Large-scale precision nutrition is an individual-centred approach focusing on behavioural modification in large num-
bers, and not a true population approach as defined by Geoffrey Rose.
• Large-scale precision nutrition is likely to have a limited impact on obesity at a population level as it neglects popula-
tion causes of obesity that are rooted in obesogenic environments.
• Early adoption and achievement of improved dietary habits based on precision nutrition are more likely among more
socially privileged members of the population, which would exacerbate socioeconomic inequalities in diet and obesity.
• If taken alone, interventions based on large-scale precision nutrition are unlikely to improve dietary intake or reduce
obesity at a population level.
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from eating behaviour, physical activity, deep phenotyp-
ing, nutrigenomics, microbiomics/metagenomics and
metabolomics37–42 (Table 1). These data serve to define
the appropriate diet for each individual, or more realisti-
cally, each population sub-stratum.49,52 Different amounts
of data can be collected and analysed depending on the in-
frastructure availability and financial resources. For exam-
ple, in the Food4Me trial, the intervention involved the
delivery of personalized nutrition advice based on data
from: (i) current diet; or (ii) diet plus phenotypic traits
such as waist circumference, serum glucose, total
cholesterol, carotenes and omega 3 index; (iii) diet and
phenotype plus genotype (i.e. specific variants on five diet-
responsive genes).44
Once the desired level of precision/information is de-
fined, data can be collected on a large scale using personal
smartphones and other relatively inexpensive and reliable
wearable devices, such as an electronic food diary and
wristband for accelerometry.38,39 In parallel, new tools
(Table 1), such as dried blood spot testing42 already rou-
tinely used for the Guthrie test in newborns,53 and simple
stool kits,36,54 enable biosample collection from home or a
Table 1. Potential sources of data for tailored nutritional advice in large-scale precision nutrition interventions
Data Aims of data collection Methods to produce data Infrastructures and tools to col-
lect, analyse and store data
Eating behaviour To evaluate:
• Dietary intake (e.g. food
consumption, use of nutrient
supplements)
• Eating behaviour
Dietary assessment on several days
using:
• Online food diary
• Smartphone applications (self-
description and quantification of
consumed foods)
• Digital photography (semi-auto-
matic identification and quantifi-
cation of consumed foods)
• Dried blood spot testing
• Saliva swabs
• Stool kits
• Shipment material
• Local pharmacy networks
• Accelerometers
• Smartphone and other digital
technologies
• Biobanks
• Linkage with electronic
health records
• Biomedical laboratories
• Artificial intelligence etc.
Physical activity To measure physical activity
level
To estimate energy expenditure
Accelerometry techniques using:
• Wearable/portable devices (e.g.
wristband)
• Online questionnaire
Deep
phenotyping
To assess:
• Body composition
• Nutritional status
• Other risk factors for
diet-related diseases
Anthropometric measurements
(e.g. weight, waist circumfer-
ence, bone densitometry)
Clinical chemistry from various
bio-samples (e.g. plasma, urine,
saliva) to assess visceral fat dis-
tribution, insulin resistance,
low-density lipoprotein choles-
terol, nutrient deficiencies, etc.
Nutrigenomics To look for genetic variants
associated with diet-related
diseases and/or responsive to
dietary changes
DNA extraction and genotyping of
selected loci from whole-blood
samples
Microbiomics/
metagenomics
To understand the interplay
between diet and gut
microbiota
Faeces collection to sequence the
microorganisms present in the
gut for microbial profiling and
detection of dysbiosis
Metabolomics To understand how the body
metabolizes/uses nutrients
Complex chemical analyses from
biosamples (e.g. serum, plasma,
urine) using:
• Nuclear magnetic resonance
spectroscopy
• Mass spectrometry-based
techniques
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local pharmacy. The Food4Me intervention was entirely
internet-delivered, for instance. Participants themselves
collected both biosamples, using the saliva swabs for geno-
typing and dried blood spots for phenotyping. They fol-
lowed online demonstrations, and sent their biological
material by conventional mail.44 The advances of labora-
tory analytical techniques (e.g. DNA sequencing, mass
spectrometry),39,42 bioinformatics, and artificial intelli-
gence (e.g. machine-learning algorithms, deep learn-
ing)36,38,55,56 render the analysis and interpretation of
large datasets less and less expensive and time-consuming.
Lastly, smartphone applications allow large-scale dis-
semination of personalized advice directly to individuals.
For instance, the applications delivered by the companies
DayTwo57 and Viome58 can provide a personal score for
foods or recipes regarding their potential positive or nega-
tive impact on blood glucose level. The enterprise habit59
even offers detailed menu plans to comply with personal-
ized recommended intake in terms of protein, carbohy-
drate and fat.
Large-scale precision nutrition: promises
and challenges
The central promise of large-scale PN is personalized inter-
ventions based on more: (i) preventive (predictive and ac-
curate); (ii) practical (understandable and implementable);
and (iii) dynamic nutritional advice than ‘one-size-fits-all’
guidelines.39 First, PN advocates presume that nutritional
advice is likely to be more predictive because the personal
risk of developing specific diseases (e.g. based on polygenic
risk scores) and biomedical context can be consid-
ered.40,49,60 Advice could also be more accurate due to
more precise dietary intake and nutritional status assess-
ment61–65 and better anticipation of interpersonal variabil-
ity in food metabolic response.36,66,67 Second, personalized
nutritional advice may be easily understood, as messages
could be delivered in a simpler way using modern commu-
nication techniques.68,69 Advice may also be more imple-
mentable as adapted to actual food consumption, personal
food preferences and lifestyle.68–70 Third, nutritional ad-
vice would evolve following the personal dietary and bio-
medical evolutions of each individual as automatically
processed and refined over time through new data.39 In
sum, large-scale PN promises better individual risk identifi-
cation through comprehensive screening and behavioural
modification in line with these identified risks.
At present, large-scale PN faces two main challenges,
however. On the one hand, its application on a large scale
raises organizational, legal and ethical questions, notably
regarding biobank management, data protection and in-
formed consent.42,52,71 However, these technical
challenges are currently being addressed by some countries
that have launched large-scale precision medicine projects,
such as the Precision Medicine Initiative in one million US
residents,72 and the human biomonitoring project
(HBM4EU) in 28 European countries.73 On the other
hand, the effectiveness associated with both identifying the
individual risk and delivering personal messages for pre-
vention and treatment of obesity-related disease is dis-
puted.4,38,40,74–77 The 2018 Lancet review by Wang and
Hu38 concluded that evidence is currently lacking to sup-
port the additional benefits of PN over ‘one-size-fits-all’
nutrition intervention in the prevention and treatment of
type 2 diabetes. Evidence regarding effectiveness and cost-
effectiveness of large-scale PN in the general population is
even scarcer. To date, the Food4Me trial has determined
that participants receiving personalized advice had a
healthier diet compared with controls receiving standard
guidelines after the 6-month intervention (completion rate:
79%).78 However, no significant changes in weight or
waist circumference were observed, even when phenotypic
or genotypic data were considered to personalized diet.
The question of effectiveness on population health will
probably remain open for some years.
Obese individuals and obese populations
In public health, two main traditional strategies have
existed for preventive interventions: high-risk and popula-
tion approaches.50,51 The traditional population approach
seeks an improvement of overall population health by
shifting the distribution of exposure risk in a favourable di-
rection in the entire population (Figure 1A). With the as-
sumption that ‘a large number of people at a small risk
may give rise to more cases of disease than the small num-
ber who are at a high risk’, the population approach con-
trasts with the high-risk approach.50 The high-risk
approach proposes targeted interventions addressed only
to individuals screened for their higher probability of de-
veloping the disease.50
Large-scale PN targets the whole population in the
spirit of a traditional population approach. Both preven-
tive strategies can be used for primary and secondary pre-
vention. However, large-scale PN interventions
substantially differ from the traditional population inter-
ventions, in the way of achieving the distribution shift. The
former targets individual risk with precision behavioural
measures in large numbers, whereas the latter targets over-
all population risk with structural/environmental meas-
ures, as shown below.
In the 1985 seminal article ‘Sick individuals and sick
populations’,50 still considered relevant for modern public
health,79 Geoffrey Rose suggested a distinction be made
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between two kinds of disease determinants. First, the
causes of cases explain why individuals become sick (i.e.
individual risk). Second, the causes of incidence explain
why certain populations become sick, whereas others do
not (i.e. population risk). Rose,50,51 and later Schwartz
and Diez-Roux,80 demonstrated that the causes of cases
and of incidence are not necessarily the same, even if they
are often related. Using empirical examples for hyperten-
sion and hypercholesterolaemia, Rose showed that causes
of cases originate generally from the individual variation in
genetic, social and behavioural factors, or a mixture of
them (i.e. what we call today gene-environment interac-
tions).51 As for the causes of incidence, they originate in-
stead from the population variation in collective and
societal characteristics.51
Returning to the issue of obesity, Rose would argue that
the causes of some individuals becoming obese differ from
the causes of some populations becoming obese. Table 2
provides examples of the distinction between causes of
obesity in individuals and those in populations, knowing
that inadequate diet and lack of physical activity are com-
mon causes at both individual and population levels. Based
on the determinants listed in Table 2, we observe that the
causes of incidence are largely related to the living condi-
tions encouraging excessive food intake and discouraging
physical activity. Others have grouped these determinants
under the umbrella term of obesogenic environments.81–88
As for large-scale PN, it accounts only for some of the
causes of obesity in individuals: e.g. genetic predisposition,
gut microbial dysbiosis and lack of food and nutrition liter-
acy regarding the meaning of healthy eating. By definition,
as PN is an individualized approach, it does not address
any causes of incidence. That is why we define large-scale
PN as an individual-centred approach in large numbers,
rather than a true population approach.
Individual-centred interventions targeting behaviour
change in large numbers can bring benefits to some indi-
viduals or sub-strata in the population. For example, it
could allow early detection of rare forms of monogenic
obesity, such as leptin deficiency due to LEP gene muta-
tions.89,90 However, such interventions are less valuable
for overall population health, especially in the case of com-
mon diseases with reduced penetrance, such as obesity.51,91
We will now discuss these limitations.
Limitations of individual-centred strategies
for population health
Individual-centred strategies often offer temporary and
palliative, rather than radical, success at a population level
because they do not alter the conditions that affect the
overall distribution.50,79 In other words, helping individu-
als to reduce their individual level of risk exposure does
not address the root of the problem determining popula-
tion risk exposure.51 For obesity, the root of the problem
of inadequate dietary intake in most high-income popula-
tions is mainly the obesogenic food environment, as men-
tioned previously.
High-energy and ultra-processed foods rich in sodium,
added sugars and saturated fats are widely available in
shops and restaurants, and hence in households.92,93
This is particularly applicable for people of lower
Figure 1. Impact of public health interventions on health. A. Intended ef-
fect of Rose’s population strategy on risk of exposure (i.e. large mean
effect and unchanged standard deviation after the intervention). B.
Desirable impact of public health interventions on dietary intake (i.e.
large mean effect and decreased standard deviation after the interven-
tion). C. Probable impact of large-scale precision nutrition on dietary in-
take (i.e. small mean effect and increased standard deviation after
intervention). Solid line: distribution of risk/dietary intake before the in-
tervention. Dashed line: distribution of risk/dietary intake after the
intervention.
International Journal of Epidemiology, 2018, Vol. 0, No. 0 5
D
ow
nloaded from
 https://academ
ic.oup.com
/ije/advance-article-abstract/doi/10.1093/ije/dyy274/5240939 by U
niversite and EPFL Lausanne user on 21 D
ecem
ber 2018
socioeconomic status (SES), who tend to experience a more
prominent obesogenic food environment in their neigh-
bourhoods.85,94,95 For example, lack of access to shops/
supermarkets to buy fresh healthy products and over-
exposure to fast-food restaurants have been documented in
the US poorer neighbourhoods.85,94,95 Moreover, high-
energy and ultra-processed foods tend to cost less than
healthier alternatives.96–99 High-energy and ultra-
processed foods are also heavily advertised,100,101 promot-
ing their over-consumption especially in children.102,103 In
addition, food is sold in large portion sizes encouraging
overeating.87 Of note, social and cultural norms (e.g. re-
duction of time and/or skills to shop, prepare and eat food,
and frequent snacking) tend to favour imbalanced diets
and excessive food intake.104,105 These social, cultural,
economic and political barriers hinder healthy eating on a
daily basis. If these barriers persist at a population level,
the weight loss success of some individuals, thanks to
large-scale PN, might be attenuated by the future weight
gain of their neighbours or children who are exposed to
the same unchanged obesogenic environments. This puts
them continually at risk of obesity.106
Similarly, if the root causes of disease in the population are
not addressed, individual-centred strategies tend to be behav-
iourally and culturally difficult to maintain over time.50,79
Namely, implementing behaviour change at an individual
level becomes challenging when ‘social norms’ (i.e. peers and
environment) are not altered. Deviation from norms necessi-
tates constant effort to sustain alternative behaviours.107–110
This might enlighten us as to why individual-centred pro-
grammes, aimed at changing eating behaviour and/or main-
taining weight loss in a priori motivated people, have
regularly yielded disappointing results in the long term.111–113
PN advocates could argue that knowing the higher per-
sonal risk of obesity might further motivate people to
change their diet. A systematic review of seven randomized
and quasi-randomized controlled trials114 and a more re-
cent trial115 however did not support this hypothesis. They
found that communicating DNA-based risk estimates for
common complex diseases did not enhance eating behav-
iour compared with non-DNA-based risk estimates or no
risk estimates at all. It seems, indeed, that targeting indi-
vidual eating behaviour with rational advice on food
choices without simultaneously tackling the social, cul-
tural, economic and political conditions in which behav-
iours occur is unlikely to generate large, long-term dietary
changes at a population level.
Together with efficacy, public health interventions aim
at maximizing equity or at least mitigating inequity.91,116
In other words, desirable population interventions should
have a large mean effect size together with a decreased
standard deviation (Figure 1B). Applied to large-scale PN,
desirable interventions should reduce the gap between
those with the best and worse dietary intake. This means
that they should have the most impact on groups with
poorer dietary intake, often those of lower SES.24,117,118
However, several reviews have shown that individual-
centred public health interventions targeting behavioural
changes to improve nutrition119,120 or health121,122 pro-
vide less benefit to lower SES groups. For example, Sumar
and McLaren123 demonstrated that public information
campaigns about the importance of folic acid intake
among childbearing-aged women (i.e. an intervention re-
quiring individual decisions to change behaviour) were
more likely to increase socioeconomic inequalities in folate
status than staple food fortification with folic acid (i.e. an
Table 2. Non-exhaustive list of determinants of obesity in individuals vs those of obese populations in most high-income
countries
Causes of cases: individual risk
Why do some individuals in a population become obese?
Causes of incidence: population risk
Why do some populations become obese whereas others do not?
Common causes Quantitative and qualitative imbalance in diet
Lack of physical activity
Distinctive causes Genetic predisposition
Diseases, metabolic and endocrine disorders
Medications associated with weight gain
Lack of richness and diversity in gut microbiota
Age
Lack of food and nutrition literacy
Psychological factors
Food markets making high-energy and ultra-processed foods
widely available, low-priced, delivered in large portion sizes,
and/or prominently marketed
Agricultural policies and subsidies promoting the production of
less healthy foods
Built environment and transportation policies promoting physi-
cal inactivity
School and workplace environment not encouraging healthy eat-
ing and physical activity
Loss of traditional culture around food, cooking and meals
Values associated with slimness and fatness
6 International Journal of Epidemiology, 2018, Vol. 0, No. 0
D
ow
nloaded from
 https://academ
ic.oup.com
/ije/advance-article-abstract/doi/10.1093/ije/dyy274/5240939 by U
niversite and EPFL Lausanne user on 21 D
ecem
ber 2018
intervention at a policy level requiring no individual deci-
sion making).
Inequalities resulting from individual-centred interven-
tions targeting the entire population can be understood
through the ‘capability approach’, developed by Amartya
Sen.124,125 He stated that people with the same amount of
resources at hand are not equal in capacity, that is in what
they are able to actually achieve with these resources.
Specifically to health, Link and Phelan’s fundamental cause
theory126,127 states that individuals of higher SES have a
wider range of ‘flexible resources’ with regard to knowl-
edge, wealth, power and social networks than individuals
of lower SES. Thanks to these resources, they can better
understand information, afford and become motivated to
engage in a larger range of activities focusing on their
health improvement. In essence, control over the determi-
nants of diet and the motivation to act on it is unequally
distributed within a population.
These theories, plus the role of obesogenic neighbour-
hoods, may partly explain why individuals of higher SES
have already taken the most advantage of previous public
health individual-centred interventions and thus have
lower obesity prevalence than less privileged individu-
als.10,25,26 From this observation, and building on the fun-
damental cause theory,126,127 we believe that smartphone
applications delivering tailored nutritional advice, albeit
free, may be more or less attractive and differentially used
according to SES. Early adoption and achievement of im-
proved dietary habits is hence more likely among more so-
cially privileged members of the population. This could
exacerbate socioeconomic inequalities in diet and in obe-
sity. This is not only an equity concern, but also one of effi-
cacy. Indeed, if mostly privileged groups in the population
improve their eating habits, this would have a limited im-
pact on overall population health, since they already dem-
onstrate a lower risk of obesity and obesity-related disease.
Conclusion
Some public health actors have become enthused by the
central promise of PN to better identify the individual risks
and suggest targeted dietary modification. They expect PN
applied at a large scale to improve populations’ diet and
health. We showed, however, that individual-centred inter-
ventions directed to behaviour change, such as large-scale
PN, are likely to have a limited and unequal impact on diet
and obesity incidence at a population level (Figure 1C),
particularly if the obesogenic environments are not
addressed in the first place.
We nevertheless believe that knowledge and technolo-
gies from large-scale PN (Table 1) may provide improved
solutions to two recurring concerns in nutritional
epidemiology: (i) the accurate assessment of food and
nutrients intakes, together with physical activity, in rela-
tion to energy intake and expenditure; and (ii) the long-
term monitoring of nutritional status at individual and
population levels. This may improve or validate our
understanding of the impact of dietary intakes and
changes on the personal risk of diseases and related biolog-
ical pathways.36,38,41,65,128 Similarly, methods used in
large-scale PN could complement traditional subjective
and/or memory-based dietary assessment methods,
such as food frequency questionnaires and 24-h dietary
recalls.38,39,41,61,63,64 Overall, this may help confirm or re-
fine dietary guidelines for specific population sub-strata.
Despite the potential for causal inference and population
surveillance, we conclude that PN on a large scale would
be of limited interest for public health interventions in the
prevention of common polygenic diseases, such as obesity.
The impact of large-scale PN on populations’ health is
likely to be minor and unevenly distributed in the popula-
tions in the absence of complementary social and struc-
tural/environmental measures.
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